Occurrence of Relative Bradycardia and Relative Tachycardia in Individuals Diagnosed With COVID-19
Copyright © 2022 Natarajan, Su and Heneghan..
The COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become one of the worst global pandemics of the century. Wearable devices are well suited for continuously measuring heart rate. Here we show that the Resting Heart Rate is modified for several weeks following a COVID-19 infection. The Resting Heart Rate shows 3 phases: 1) elevated during symptom onset, with average peak increases relative to the baseline of 1.8% (3.4%) for females (males), 2) decrease thereafter, reaching a minimum on average ≈13 days after symptom onset, and 3) subsequent increase, reaching a second peak on average ≈28 days from symptom onset, before falling back to the baseline ≈112 days from symptom onset. All estimates vary with disease severity.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Frontiers in physiology - 13(2022) vom: 25., Seite 898251 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Natarajan, Aravind [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bradycardia |
---|
Anmerkungen: |
Date Revised 16.07.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3389/fphys.2022.898251 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341429368 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341429368 | ||
003 | DE-627 | ||
005 | 20231226011748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fphys.2022.898251 |2 doi | |
028 | 5 | 2 | |a pubmed24n1138.xml |
035 | |a (DE-627)NLM341429368 | ||
035 | |a (NLM)35620612 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Natarajan, Aravind |e verfasserin |4 aut | |
245 | 1 | 0 | |a Occurrence of Relative Bradycardia and Relative Tachycardia in Individuals Diagnosed With COVID-19 |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Copyright © 2022 Natarajan, Su and Heneghan. | ||
520 | |a The COVID-19 disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become one of the worst global pandemics of the century. Wearable devices are well suited for continuously measuring heart rate. Here we show that the Resting Heart Rate is modified for several weeks following a COVID-19 infection. The Resting Heart Rate shows 3 phases: 1) elevated during symptom onset, with average peak increases relative to the baseline of 1.8% (3.4%) for females (males), 2) decrease thereafter, reaching a minimum on average ≈13 days after symptom onset, and 3) subsequent increase, reaching a second peak on average ≈28 days from symptom onset, before falling back to the baseline ≈112 days from symptom onset. All estimates vary with disease severity | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a bradycardia | |
650 | 4 | |a digital health | |
650 | 4 | |a heart rate | |
650 | 4 | |a heart rate variability | |
650 | 4 | |a tachycardia | |
700 | 1 | |a Su, Hao-Wei |e verfasserin |4 aut | |
700 | 1 | |a Heneghan, Conor |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in physiology |d 2010 |g 13(2022) vom: 25., Seite 898251 |w (DE-627)NLM205532799 |x 1664-042X |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g day:25 |g pages:898251 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fphys.2022.898251 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |b 25 |h 898251 |